Navigation Links
Isis Initiates Phase 1 Studies with Isis-GCGRRx and Isis-GCCRRx to Treat Type 2 Diabetes
Date:11/2/2011

ovascular, metabolic and severe and rare/neurodegenerative diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, mipomersen, following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT

This press release includes forward-looking statements regarding Isis Pharmaceuticals and the discovery, development and potential of ISIS-GCGRRx and ISIS-GCCRRx for the treatment of type 2 diabetes.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of mipomersen, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2010 and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other document
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
2. Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale
3. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
4. CareFusion Initiates Class I Recall of EnVe Ventilators
5. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
6. ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis
7. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
8. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
9. Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
10. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
11. Omthera Pharmaceuticals, Inc. Initiates Phase III ESPRIT Trial of Add-on Epanova™ to Statin Therapy in Patients with Hypertriglyceridemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ... developing new, patent-pending technologies poised to redefine how consumers receive ... hold a business update teleconference and webcast for shareholders and ... at 4:30 PM ET. Fuse Science, Inc. ... call and will be joined by Rubin Hanan ...
(Date:5/17/2013)... May 17, 2013 Oramed Pharmaceuticals ... oral drug delivery systems, announced today that the United ... Company,s Investigational New Drug application(IND) for ORMD-0801, its oral ... have the FDA clearance to proceed," stated ... trial is a major milestone for Oramed and we ...
(Date:5/16/2013)... PLAINFIELD, N.J. , May 16, 2013  PTC ... registration statement on Form S-1 with the U.S. Securities ... public offering of its common stock. The number of ... the offering have not been determined. (Logo:  ... Credit Suisse are acting as joint book-running managers for ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
(Date:5/18/2013)... New York, NY (PRWEB) May 18, 2013 ... of consistent efforts, SizeItUp formally announced the integration ... The redesigned 2012 Hyundai Genesis is set to stun the ... comfort and style. 2012 Hyundai Genesis is marked as the ... database and heads the vehicles lined up for the year ...
(Date:5/18/2013)... AL (PRWEB) May 18, 2013 Although ... malignant tumors, the association between obesity and esophageal adenocarcinoma, ... for other obesity-related tumors. As reported on ... people are almost twice as likely as those of ... Although the relationship between obesity and esophageal cancer is ...
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
(Date:5/18/2013)... Los Angeles, Ca (PRWEB) May 18, 2013 ... lot of people. But among the horde of new weight ... the one most talked about. Recent studies about this newest ... to achieve one’s ideal body shape. , Garcinia Cambogia is ... looks like a tamarind. Eating the fruit can suppress a ...
(Date:5/18/2013)... May 18, 2013 John Ravera, D.D.S., a ... addition of a new member to his dental team, Courtney ... in the field for over 10 years. She received her ... and was elected a member of Sigma Pi Alpha, a ... Marino enjoys working with patients of all ages, helping them ...
Breaking Medicine News(10 mins):Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2
... DETROIT Why are African Americans more likely than Caucasians to ... die from the disease? While the answer isn,t a simple ... in part, be to blame, according to a new study from ... are more likely to be past or current smokers, one of ...
... chronic vulvar pain (pain at the opening to the vagina) ... long periods of time, painful, if not impossible. A ... women in the metro Detroit area, found that more than ... some point in their lives. However, only two percent of ...
... State University research groups have teamed up with the ... & Manufacturing North America, Inc. (TEMA), to work on ... Safety Research Center (CSRC). The CSRC ... the safety of vehicles, drivers, passengers and pedestrians. Over ...
... a particlular gene,s link to optimism, self-esteem and "mastery," the belief ... psychological resources for coping well with stress and depression. ... years, and it is not the gene I expected," said Shelley ... author of the new research. "I knew there had to be ...
... 2011) Research conducted by Boston College neuroscientist Sean MacEvoy ... evidence of a new way of considering how the brain ... published in the latest issue of Nature Neuroscience . ... resonance image (fMRI) to help them identify how the brain ...
... , TUESDAY, Sept. 13 (HealthDay News) --,A healthy lifestyle ... of vegetables -- could ward off many cases of heart failure, ... 18,000 men and nearly 20,000 women from Finland ranging in age ... time, 638 of the men and 445 of the women developed ...
Cached Medicine News:Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 3Health News:Chronic vulvar pain a reality for more than 100,000 women in southeast Michigan 2Health News:Wayne State University partners with Toyota on safety research 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 3Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 4Health News:Researchers utilize neuroimaging to show how brain uses objects to recognize scenes 2Health News:Lifestyle Changes May Prevent Heart Failure 2
Malaria device / strip (2 line, PAN specific-pLDH)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of antibodies to Malaria in Human whole blood....
Medicine Products: